Gastro-enteritis - Cryptosporidium species
Advices
| Priority | Medication | Remarks |
|---|---|---|
|
Priority: 1st choice |
Medication:
|
Remarks:
niet behandelen, tenzij langdurige klachten |
|
Priority: 2nd choice |
Medication:
|
Remarks:
nitazoxanide po gedurende 3 dagen: 1-3 jaar: 2 dd 100 mg, 4-11 jaar: 2 dd 200 mg, > 11 jaar: 2 dd 500 mg |
| Priority | Medication | Remarks |
|---|---|---|
|
Priority: 1st choice |
Remarks:
Meest effectieve therapie is herstel van eigen afweer (bv door HAART bij HIV of verminderen immuunsuppressie) |
|
|
Priority: 2nd choice |
Remarks:
nitazoxanide po gedurende 14-28 dagen: 1-3 jaar: 2 dd 100 mg, 4-11 jaar: 2 dd 200 mg, > 11 jaar: 2 dd 500 mg |
|
|
Priority: 2nd choice alternative |
Medication: paromomycine po 14 days +
azitromycine po 10mg/kg 1dd 14 days |
Remarks:
Behandelduur eventueel verlengen tot 28 dagen. Dosis paromomycine: https://www.kinderformularium.nl/geneesmiddel/25/paromomycine. Dosis azitromycine: https://www.kinderformularium.nl/geneesmiddel/309/azitromycine. |
Sources
-
Pubmed.gov publication # 19632225
Rossignol JF (2010) Cryptosporidium and Giardia: treatment options and prospects for new drugs. Exp Parasitol. 124:45-53.
-
Pubmed.gov publication # 20689422
Cabada MM, White AC Jr. (2010) Treatment of cryptosporidiosis: do we know what we think we know? Curr Opin Infect Dis. 23(5):494-9.
-
Pubmed.gov publication # 19400754
Pantenburg B, Cabada MM, White AC jr. (2009) Treatment of cryptosporidiosis. Expert Rev Anti Infect Ther 7: 385-91
-
Pubmed.gov publication # 17335543
Abubakar I, Aliyu SH, Arumugam C, Usman NK, Hunter PR (2007) Treatment of cryptosporidiosis in immunocompromised individuals: systematic review and meta-analysis. Br J Clin Pharmacol. 63:387-93.
- SWAB Guideline IX - Acute infectieuze diarree
Antimicrobial resources
The following antimicrobial agents have been used in these recommendations:
- paromomycine
- azitromycine
Menu position
Metadata
Swab vid: G-390667.2
Updated: 03/26/2021 - 11:32
Status: Published